Surrozen, Inc/de Form 4 insider transactions
NASDAQ
SRZN
Surrozen, Inc/deSurrozen's Chief Operating Officer, Charles O. Williams, sold 1,566 shares of common stock to cover tax obligations following the vesting of 3,500 restricted stock units.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen's Executive Vice President of Research, Li Yang, acquired 1,666 shares of common stock through the company's Employee Stock Purchase Plan.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen, Inc.'s Chief Operating Officer, Charles O Williams, acquired 1,666 shares of common stock at $8.11 per share through the company's 2021 Employee Stock Purchase Plan.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen, Inc. CEO Craig C Parker acquired 1,553 shares of common stock at $8.11 per share through the company's Employee Stock Purchase Plan.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen Director and 10% Owner Tim Kutzkey, through affiliated funds, acquired over 36,000 shares of common stock in early December 2025.
NASDAQ
SRZN
Surrozen, Inc/deThe Column Group, a significant shareholder and director-affiliated entity, reported acquiring additional common stock in Surrozen, Inc. through multiple transactions in early December 2025.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen, Inc. Director and 10% owner Tim Kutzkey, through affiliated investment funds, acquired 315,457 shares of common stock at $12.65 per share on November 13, 2025.
NASDAQ
SRZN
Surrozen, Inc/deThe Column Group, a 10% owner and director, acquired over 315,000 shares of Surrozen, Inc. common stock for approximately $4 million.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen, Inc.'s Chief Financial Officer, Andrew Pedrum Maleki, was granted 50,000 employee stock options with an exercise price of $12.94.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen, Inc.'s Executive Vice President of Research, Li Yang, acquired 400 shares of common stock at $8.06 per share through the company's Employee Stock Purchase Plan.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen, Inc.'s CFO and COO, Charles O. Williams, has reported a future acquisition of 400 shares of common stock at $8.06 per share, scheduled for June 13, 2025, through the company's Employee Stock Purchase Plan.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen, Inc. CEO and Director Craig C Parker acquired 400 shares of common stock at $8.06 per share through the company's Employee Stock Purchase Plan.
NASDAQ
SRZN
Surrozen, Inc/deDirector Eric Bjerkholt reports the acquisition of options to purchase 1,333 shares of Surrozen, Inc. common stock.
NASDAQ
SRZN
Surrozen, Inc/deDirector Christopher Chai acquired options to purchase 1,333 shares of Surrozen, Inc. stock at an exercise price of $6.50, vesting annually from May 14, 2026.
NASDAQ
SRZN
Surrozen, Inc/deMary Haak-Frendscho, a director of Surrozen, Inc., reported the acquisition of options to purchase 1,333 shares of common stock.
NASDAQ
SRZN
Surrozen, Inc/deDirector Mace Rothenberg acquired options to purchase 1,333 shares of Surrozen, Inc. common stock.
NASDAQ
SRZN
Surrozen, Inc/deDirector David J. Woodhouse acquired options to purchase 1,333 shares of Surrozen, Inc. common stock.
NASDAQ
SRZN
Surrozen, Inc/deDirector Anna Berkenblit acquired options to purchase 1,333 shares of Surrozen, Inc. common stock on May 14, 2025.
NASDAQ
SRZN
Surrozen, Inc/deYang Li, Executive Vice President of Research at Surrozen, Inc., reports the acquisition of stock options and restricted stock units (RSUs) in a recent SEC Form 4 filing.
NASDAQ
SRZN
Surrozen, Inc/deCharles O. Williams, CFO and COO of Surrozen, Inc., reports the acquisition of restricted stock units and options in the company.
NASDAQ
SRZN
Surrozen, Inc/deCraig C. Parker, CEO of Surrozen, Inc., reports the acquisition of stock options and restricted stock units (RSUs) in a recent SEC Form 4 filing.
NASDAQ
SRZN
Surrozen, Inc/deDirector Tim Kutzkey reports the acquisition of stock options in Surrozen, Inc.
NASDAQ
SRZN
Surrozen, Inc/deThe Column Group and affiliated entities report changes in beneficial ownership of Surrozen, Inc. common stock and warrants following a private placement, including adjustments to warrant exercise prices and the acquisition of second tranche units.
NASDAQ
SRZN
Surrozen, Inc/deCharles O. Williams, CFO and COO of Surrozen, Inc., filed a Form 4 detailing the repricing and cancellation of certain warrant series on March 24, 2025.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen's CEO, Craig C. Parker, executed a series of transactions involving the repricing and cancellation of stock warrants on March 24, 2025.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen's CEO, Craig Parker, has been granted 100,000 stock options, exercisable starting February 1, 2025, according to a recent SEC filing.
NASDAQ
SRZN
Surrozen, Inc/deYang Li, Executive Vice President of Research at Surrozen, Inc., acquired 35,000 stock options on January 17, 2025, which vest monthly starting February 1, 2025.
NASDAQ
SRZN
Surrozen, Inc/deCharles O. Williams, CFO and COO of Surrozen, Inc., acquired 45,000 stock options on January 17, 2025, which vest monthly starting February 1, 2025.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen's Executive Vice President, Research, Yang Li, reports the acquisition of 2,500 shares through vested restricted stock units and the sale of 843 shares to cover withholding taxes.